Cargando…
Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767689/ https://www.ncbi.nlm.nih.gov/pubmed/35042473 http://dx.doi.org/10.1186/s12882-021-02625-2 |
_version_ | 1784634786561654784 |
---|---|
author | Tollitt, James Allan, Stuart M. Chinnadurai, Rajkumar Odudu, Aghogho Hoadley, Margaret Smith, Craig Kalra, Philip A. |
author_facet | Tollitt, James Allan, Stuart M. Chinnadurai, Rajkumar Odudu, Aghogho Hoadley, Margaret Smith, Craig Kalra, Philip A. |
author_sort | Tollitt, James |
collection | PubMed |
description | BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis CKD (ND-CKD) with and without stroke. METHODS: A propensity matched sample from > 3000 Salford Kidney Study (SKS) patients, differentiated by previous stroke at study recruitment, had stored plasma analyzed for interleukin- 6 (IL-6), Von Willebrand Factor (VWF) and C-reactive protein (CRP). Multivariable cox regression analysis investigated associations between inflammation and death, end-stage renal disease (ESRD) and future non-fatal cardiovascular events (NFCVE). RESULTS: A total of 157 previous stroke patients were compared against 162 non-stroke patients. There were no significant differences in inflammatory biomarkers between the two groups. Previous stroke was associated with greater mortality risk, hazard ratio (HR) (95% CI) was 1.45 (1.07–1.97). Higher inflammatory biomarker concentrations were independently associated with death but not ESRD or NFCVE in the total population. For each 1 standard deviation (SD) increase in log IL-6, VWF and CRP, the HR for all-cause mortality were 1.35 (1.10–1.70), 1.26 (1.05–1.51) and 1.34 (1.12–1.61), respectively. CRP retained its independent association (HR 1.47 (1.15–1.87)) with death in the stroke population. CONCLUSION: Previous stroke is an important determinant of mortality. However, the adverse combination of stroke and ND-CKD does not seem to be driven by higher levels of inflammation detected after the stroke event. Biomarkers of inflammation were associated with worse outcome in both stroke and non-stroke ND-CKD patients. TRIAL REGISTRATION: 15/NW/0818. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02625-2. |
format | Online Article Text |
id | pubmed-8767689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87676892022-01-19 Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? Tollitt, James Allan, Stuart M. Chinnadurai, Rajkumar Odudu, Aghogho Hoadley, Margaret Smith, Craig Kalra, Philip A. BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis CKD (ND-CKD) with and without stroke. METHODS: A propensity matched sample from > 3000 Salford Kidney Study (SKS) patients, differentiated by previous stroke at study recruitment, had stored plasma analyzed for interleukin- 6 (IL-6), Von Willebrand Factor (VWF) and C-reactive protein (CRP). Multivariable cox regression analysis investigated associations between inflammation and death, end-stage renal disease (ESRD) and future non-fatal cardiovascular events (NFCVE). RESULTS: A total of 157 previous stroke patients were compared against 162 non-stroke patients. There were no significant differences in inflammatory biomarkers between the two groups. Previous stroke was associated with greater mortality risk, hazard ratio (HR) (95% CI) was 1.45 (1.07–1.97). Higher inflammatory biomarker concentrations were independently associated with death but not ESRD or NFCVE in the total population. For each 1 standard deviation (SD) increase in log IL-6, VWF and CRP, the HR for all-cause mortality were 1.35 (1.10–1.70), 1.26 (1.05–1.51) and 1.34 (1.12–1.61), respectively. CRP retained its independent association (HR 1.47 (1.15–1.87)) with death in the stroke population. CONCLUSION: Previous stroke is an important determinant of mortality. However, the adverse combination of stroke and ND-CKD does not seem to be driven by higher levels of inflammation detected after the stroke event. Biomarkers of inflammation were associated with worse outcome in both stroke and non-stroke ND-CKD patients. TRIAL REGISTRATION: 15/NW/0818. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02625-2. BioMed Central 2022-01-18 /pmc/articles/PMC8767689/ /pubmed/35042473 http://dx.doi.org/10.1186/s12882-021-02625-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tollitt, James Allan, Stuart M. Chinnadurai, Rajkumar Odudu, Aghogho Hoadley, Margaret Smith, Craig Kalra, Philip A. Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title | Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title_full | Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title_fullStr | Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title_full_unstemmed | Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title_short | Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? |
title_sort | does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in ckd patients? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767689/ https://www.ncbi.nlm.nih.gov/pubmed/35042473 http://dx.doi.org/10.1186/s12882-021-02625-2 |
work_keys_str_mv | AT tollittjames doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT allanstuartm doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT chinnadurairajkumar doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT oduduaghogho doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT hoadleymargaret doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT smithcraig doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients AT kalraphilipa doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients |